Personalized Approach to Therapy Selection in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Clinical Case
Anaplastic lymphoma kinase-positive non-small cell lung cancer (ALK-positive NSCLC) is a molecularly defined subtype of lung cancer in which the optimal sequencing of systemic therapy is essential for achieving long-term disease control. Progression involving the central nervous system (CNS) represents a particular cli...